Literature DB >> 25037085

Congenital myopathies and muscular dystrophies.

Heather R Gilbreath1, Diana Castro2, Susan T Iannaccone3.   

Abstract

The congenital muscular dystrophies (CMD) and myopathies (CM) are a diverse group of diseases that share features such as early onset of symptoms (in the first year of life), genetic causes, and high risks for restrictive lung disease and orthopedic deformities. Understanding for disease mechanism is available and a fairly well-structured genotype-phenotype correlation for all the CMDs and CMs is now available. To best illustrate the clinical spectrum and diagnostic algorithm for these diseases, this article presents 5 cases, including Ullrich congenital muscular dystrophy, nemaline myopathy, centronuclear myopathy, merosin deficiency congenital muscular dystrophy, and core myopathy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Central core myopathy; Centronuclear myopathy; Congenital muscular dystrophy; Congenital myopathy; Merosin deficiency congenital muscular dystrophy; Nemaline myopathy; Ullrich congenital muscular dystrophy

Mesh:

Year:  2014        PMID: 25037085     DOI: 10.1016/j.ncl.2014.04.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  8 in total

Review 1.  Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease.

Authors:  Nenad Bursac; Mark Juhas; Thomas A Rando
Journal:  Annu Rev Biomed Eng       Date:  2015       Impact factor: 9.590

Review 2.  Congenital muscular dystrophy: from muscle to brain.

Authors:  Raffaele Falsaperla; Andrea D Praticò; Martino Ruggieri; Enrico Parano; Renata Rizzo; Giovanni Corsello; Giovanna Vitaliti; Piero Pavone
Journal:  Ital J Pediatr       Date:  2016-08-31       Impact factor: 2.638

3.  Compound heterozygous POMGNT1 mutations leading to muscular dystrophy-dystroglycanopathy type A3: a case report.

Authors:  Kondakova Olga Borisovna; Krasnenko Anna Yurievna; Tsukanov Kirill Yurievich; Klimchuk Olesya Igorevna; Korostin Dmitriy Olegovich; Davidova Anna Igorevna; Batysheva Tatyana Timofeevna; Zhurkova Natalia Vyacheslavovna; Surkova Ekaterina Ivanovna; Shatalov Peter Alekseevich; Ilinsky Valery Vladimirovich
Journal:  BMC Pediatr       Date:  2019-04-08       Impact factor: 2.125

4.  CircRILPL1 promotes muscle proliferation and differentiation via binding miR-145 to activate IGF1R/PI3K/AKT pathway.

Authors:  Xuemei Shen; Jia Tang; Rui Jiang; Xiaogang Wang; Zhaoxin Yang; Yongzhen Huang; Xianyong Lan; Chuzhao Lei; Hong Chen
Journal:  Cell Death Dis       Date:  2021-02-01       Impact factor: 8.469

5.  A Systematic Review and Meta-Analysis of the Prevalence of Congenital Myopathy.

Authors:  Kun Huang; Fang-Fang Bi; Huan Yang
Journal:  Front Neurol       Date:  2021-11-02       Impact factor: 4.003

Review 6.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

7.  Clinico-pathological features and mutational spectrum of 16 nemaline myopathy patients from a Chinese neuromuscular center.

Authors:  Xi Yin; Chuanqiang Pu; Zhenfu Wang; Ke Li; HuiFang Wang
Journal:  Acta Neurol Belg       Date:  2021-03-19       Impact factor: 2.471

Review 8.  Treating pediatric neuromuscular disorders: The future is now.

Authors:  James J Dowling; Hernan D Gonorazky; Ronald D Cohn; Craig Campbell
Journal:  Am J Med Genet A       Date:  2017-09-10       Impact factor: 2.802

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.